Conferences and Events > Previous Events > 2018 > 20th Annual Conference of NHIVNA (Brighton 2018) >

20th Annual Conference of NHIVNA - Abstract Information

20th Annual Conference of NHIVNA - Abstract Information

Date: 28-29 June 2018

Venue: Brighton, UK
 

Abstract submission is now closed


SUITABLE TOPICS FOR ABSTRACT SUBMISSION

Access and service delivery | HIV treatment | Sexually transmitted infections | Children and pregnancy | Complications of HIV disease or treatment | Diagnosis and testing | Epidemiology and surveillance | Management issues in HIV | Age, gender and migration-related issues | Pathogenesis, transmission and prevention | Psychosocial, mental health and stigma issues

NOTES FOR PREPARING YOUR ABSTRACT
It is essential that your abstract conforms to the preparation guidelines.


IMPORTANT INFORMATION Please read carefully

1. Registration is necessary for presentation and publication of the abstract. Submissions without a registration form will not be put forward for review.
2. All research entries will be considered for a Krattinger Rennison Charitable Trust Nursing Research Award.
3. Your presentations may be eligible for one of the other conference awards. Click here for further details.


GENERAL GUIDELINES

  • All abstracts must be submitted in English
  • All abstracts must be submitted via www.nhivna.org and through the NHIVNA online abstract submission system
  • Abstract content will be reproduced as submitted; therefore proofreading beforehand is essential.



ABSTRACT FORMAT

Anonymous submission: A 'blind' selection process will be used. No identifying features such as name of hospitals, medical schools, clinics or cities should be listed in the title or text of the abstract. Do not include the names or affiliations of authors in the text of your abstract; these details must be submitted as separate pieces of information as part of the online abstract submission process.

Title: Use a concise title that indicates the nature of the study.

  • Please capitalise the first letter of the title and use lower case for the rest of the title (with the exception of proper nouns or abbreviations).
  • Please do not use a full stop at the end of the title.

Authors: Names should be typed in sentence case (please do not use all capital letters). Indicate title (Dr / Prof / Mr / Mrs / Ms) and use first initial(s) and last name. The author presenting the paper must be designated.

Affiliations: Each author should be listed by institution, city and country. Do not include department, division or laboratory.

Abstract body: Each abstract must contain no more than 2500 characters and use the Arial font in size 10. Only one data table is permitted in the body of the abstract. Once you have your abstract prepared please paste this into the template as part of the online abstract submission system. The body of the abstract should follow the general outline format on the following page.

General outline:

  • Background: brief outline of the study aims/objectives, the hypothesis/intervention to be tested, or a description of the problem.
  • Methods: method(s) used or approach taken.
  • Results: detail the results in summarised form (using statistical analysis as appropriate) with words and/or tables.
  • Conclusion: description of the main outcome of the study.

All abstracts should describe primary findings (the findings related to the aims/objectives/hypothesis) and detail studies that have been completed. Statements such as 'experiments are in progress', or 'results will be discussed' should be avoided.

Please define abbreviations in full at first mention, including names of clinical trials or studies. Please avoid citing references in the abstract.


SUBMISSION GUIDELINES

Please register with the abstract submission system and submit a username and password. Once registered with the system, please follow the onscreen directions and upload your abstract when prompted to do so. If you are submitting more than one abstract, please use the same email address and password for each abstract.

Amending your submission:: If you wish to change your answers to some of the questions on the submission form, or even to change the abstract itself, please do not submit multiple versions of the same abstract with incremental changes, please log in to the abstract submission system and click ‘edit’ against the abstract that you wish to change. The process of amending an abstract is the same as the original submission process, except that the submission form will be automatically filled in with the answers that you previously submitted.

Withdrawing an abstract: If you wish to withdraw an abstract, please contact the Conference Organiser at: conferences@nhivna.org.

All abstracts will be reviewed by the NHIVNA Executive Committee, who will allocate abstracts to be presented either orally or as a poster. The Conference Organiser will contact you to confirm which format your abstract is to take.

Delegates submitting successful poster abstracts will be given details of the required poster format. Oral presentations will be allocated a maximum of 15 minutes, which is to include time for questions.

Accepted abstracts will be published in the conference literature and in HIV Nursing. Abstracts will be reproduced from the uploaded Microsoft Word document submitted. Presentations need not be exclusive to this meeting and may be presented elsewhere. It is the responsibility of the author to obtain permission, where necessary, for the publication of the abstract in HIV Nursing.HIV Nursing
 

Abstract submission is now closed